(600993)"Mayinglong Pharmaceutical Group Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 600993 · · 18 pages · Chinese
Mayinglong Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Mayinglong Pharmaceutical
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Departure and Appointment of General Manager
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on the Listing and Trading of Restricted Shares from the Share Reform
- Announcement on Obtaining Drug Registration Certificate by Subsidiary
Follow Mayinglong Pharmaceutical into a list and get an email when it puts out news.
Follow Mayinglong Pharmaceutical